002210 — Dongsung Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSucker Stock

Annual balance sheet for Dongsung Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	22,527	20,362	5,143	4,094	6,435
Net Total Accounts Receivable
Net Total Receivables	31,074	26,561	27,903	33,083	31,291
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	79,398	71,507	49,986	54,389	60,815
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34,176	37,313	37,378	43,960	42,725
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	131,730	125,718	104,582	107,702	114,973
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	40,550	43,273	37,589	47,571	44,844
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	61,632	70,770	58,141	64,893	75,171
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	70,098	54,948	46,440	42,809	39,802
Total Liabilities & Shareholders' Equity	131,730	125,718	104,582	107,702	114,973
Total Common Shares Outstanding